Stock LBPH LONGBOARD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Longboard Pharmaceuticals, Inc.

Equities

LBPH

US54300N1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
31.58 USD -9.44% Intraday chart for Longboard Pharmaceuticals, Inc. +2.13% +423.71%
Jul. 02 Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $80 From $57, Keeps Outperform Rating MT
Jul. 01 Longboard Pharmaceuticals Gets FDA Breakthrough Therapy Designation for Seizure Treatment MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Longboard Pharmaceuticals Names Industry Veteran Randall Kaye as CMO
MT
Longboard Pharmaceuticals, Inc. Announces the Appointment of Dr. Randall Kaye as Chief Medical Officer
CI
Longboard Pharmaceuticals Appoints Jane Tiller to Board of Directors
CI
Longboard Pharmaceuticals, Inc Appoints Phillip Schneider and Paul Sekhri to Board of Directors
CI
Arena Neuroscience, Inc. Announces Appointment of Kevin Lind as President and Chief Executive Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LBPH Stock
  4. News Longboard Pharmaceuticals, Inc.
  5. Insiders